While noting that tens of thousands of drug listing records have not been updated in the past year, the US FDA this week announced that it will begin inactivating drug and manufacturing establishment listings that are not current in one month. The announcement is part of FDA’s push to encourage drugmakers to ensure that their listed human drugs and any information in their drug listings, including drug establishments, are accurate. FDA Commissioner Ned Sharpless noted in a statement that although there have not been any public health consequences as a result of the outdated listings, “inaccurate information has the potential to compromise the integrity of the FDA’s database…” Learn More